1
/
of
1
ELK Biotechnology
SKU:ELK8009
Human Anti-MPO(Anti-Myeloperoxidase Antibody) ELISA Kit
Human Anti-MPO(Anti-Myeloperoxidase Antibody) ELISA Kit
Regular price
$458.00 USD
Regular price
Sale price
$458.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
Human Anti-MPO(Anti-Myeloperoxidase Antibody) ELISA Kit
Overview
| Product name: | Human Anti-MPO(Anti-Myeloperoxidase Antibody) ELISA Kit |
| Reactivity: | Human |
| Alternative Names: | Mpo Ab |
| Assay Type: | Competitive Inhibition |
| Sensitivity: | 1.12 ng/mL |
| Standard: | 200 ng/mL |
| Detection Range: | 3.13-200 ng/mL |
| Sample Type: | Serum, plasma and other biological fluids. |
| Assay Length: | 2.5h |
| Research Area: | Enzyme & Kinase;Infection immunity;Cardiovascular biology;Hepatology; |
| Test principle: | This assay employs the competitive inhibition enzyme immunoassay technique. The microtiter plate provided in this kit has been pre-coated with Human Anti-MPO protein. Standards or samples are added to the appropriate microtiter plate wells then with a biotin-conjugated antibody specific to Human Anti-MPO. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Human Anti-MPO in the samples is then determined by comparing the OD of the samples to the standard curve. |
Standard curve
| Concentration (ng/mL) | OD | Corrected OD |
|---|---|---|
| 200.00 | 0.217 | — |
| 100.00 | 0.467 | — |
| 50.00 | 0.722 | — |
| 25.00 | 0.997 | — |
| 12.50 | 1.258 | — |
| 6.25 | 1.557 | — |
| 3.13 | 1.861 | — |
| 0.00 | 2.232 | — |

Precision
Intra-assay Precision (Precision within an assay):CV%<8%
Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-assay Precision (Precision between assays):CV%<10%
Three samples of known concentration were tested in forty separate assays to assess inter-assay precision.
Recovery
Matrices listed below were spiked with certain level of recombinant Anti-MPO and the recovery rates were calculated by comparing the measured value to the expected amount of Anti-MPO in samples.
| Matrix | Recovery range | Average |
|---|---|---|
| serum(n=5) | 84-95% | 88% |
| EDTA plasma(n=5) | 82-97% | 92% |
| Heparin plasma(n=5) | 87-99% | 94% |
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Anti-MPO and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
| Matrix | 1:2 | 1:4 | 1:8 | 1:16 |
|---|---|---|---|---|
| serum(n=5) | 95-104% | 93-105% | 82-101% | 91-103% |
| EDTA plasma(n=5) | 83-95% | 88-102% | 85-97% | 80-92% |
| Heparin plasma(n=5) | 82-93% | 96-105% | 87-98% | 85-97% |
Share
